1: Yamashiro K, Heianna J, Azama K, Iraha Y, Yamashiro T, Kinoshita R, Toita T,

Toyama M, Agena S, Maeda H, Suzuki M, Murayama S. [Maxillary Cancer with

Metastasis to the Rouviere Nodes -- Complete Response to Chemoradiotherapy Using
a Selective Intra-Arterial Infusion Technique]. Gan To Kagaku Ryoho. 2016
Feb;43(2):243-6. Japanese. PubMed PMID: 27067691.

2: Homma A, Nakamaru Y, Sakashita T, Onimaru R, Terasaka S, Tsuchiya K, Yoshida

D, Yasuda K, Hatakeyama H, Furusawa J, Mizumachi T, Kano S, Shirato H, Fukuda S.
Management for squamous cell carcinoma of the nasal cavity and ethmoid sinus: A
single institution experience. Auris Nasus Larynx. 2015 Oct;42(5):377-81. doi:
10.1016/j.anl.2015.02.005. Epub 2015 Mar 3. PubMed PMID: 25748513.

3: Kinno R, Kii Y, Uchiyama M, Owan Y, Yamazaki T, Fukui T.

5-fluorouracil-induced leukoencephalopathy with acute stroke-like presentation
fulfilling criteria for recombinant tissue plasminogen activator therapy. J
Stroke Cerebrovasc Dis. 2014 Feb;23(2):387-9. doi:
10.1016/j.jstrokecerebrovasdis.2013.01.014. Epub 2013 Feb 17. PubMed PMID:
23422344.

4: Kobayashi W, Teh BG, Sakaki H, Sato H, Kimura H, Kakehata S, Nagahata M.

Superselective intra-arterial chemoradiotherapy with docetaxel-nedaplatin for
advanced oral cancer. Oral Oncol. 2010 Dec;46(12):860-3. doi:
10.1016/j.oraloncology.2010.10.001. Epub 2010 Nov 2. PubMed PMID: 21050802.

5: Hanada K, Suda M, Kanai N, Ogata H. Pharmacokinetics and toxicodynamics of

oxaliplatin in rats: application of a toxicity factor to explain differences in
the nephrotoxicity and myelosuppression induced by oxaliplatin and the other
platinum antitumor derivatives. Pharm Res. 2010 Sep;27(9):1893-9. doi:
10.1007/s11095-010-0189-4. Epub 2010 Jun 15. PubMed PMID: 20552253.

6: Yamashita Y, Kuroda Y, Yamamoto T, Goto M. [Two cases of recurrent oral cancer

responding to radiochemotherapy with selective intra-arterial infusion of
nedaplatin]. Gan To Kagaku Ryoho. 2009 Apr;36(4):631-5. Japanese. PubMed PMID:
19381037.

7: Osawa S, Yamada T, Iwaizumi M, Hamaya Y, Takagaki K, Nishino M, Kodaira C,

Muramatsu A, Yoshida K, Sugimoto K, Futami H, Furuta T, Ikuma M. [A case of
elderly esophageal adenocarcinoma successfully treated with daily low-dose
nedaplatin (CDGP) and continuous infusion of 5-FU combined with radiation]. Gan
To Kagaku Ryoho. 2009 Feb;36(2):309-12. Japanese. PubMed PMID: 19223753.

8: Fuwa N, Kodaira T, Furutani K, Tachibana H, Nakamura T. Treatment results of

continuous intra-arterial CBDCA infusion chemotherapy in combination with
radiation therapy for locally advanced tongue cancer. Oral Surg Oral Med Oral
Pathol Oral Radiol Endod. 2008 Jun;105(6):714-9. doi:
10.1016/j.tripleo.2007.11.023. Epub 2008 Apr 24. PubMed PMID: 18439857.

9: Hanada K, Asano K, Nishimura T, Chimata T, Matsuo Y, Tsuchiya M, Ogata H. Use

of a toxicity factor to explain differences in nephrotoxicity and
myelosuppression among the platinum antitumour derivatives cisplatin, carboplatin
and nedaplatin in rats. J Pharm Pharmacol. 2008 Mar;60(3):317-22. doi:
10.1211/jpp.60.3.0006. PubMed PMID: 18284811.

10: Fuwa N, Kodaira T, Furutani K, Tachibana H, Nakamura T. A new method of

selective intra-arterial infusion therapy via the superficial temporal artery for
head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008
Jun;105(6):783-9. doi: 10.1016/j.tripleo.2007.07.031. Epub 2008 Feb 21. PubMed
PMID: 18206406.

11: Aoki K, Tatebayashi S, Imai Y, Yamakawa N, Yagyuu T, Kajihara A, Nakagawa H,

Kirita T. [Clinical trial of chemotherapy by superselective intra-arterial
infusion of nedaplatin (CDGP) and 5-FU with concurrent radiotherapy for advanced
oral cancer]. Gan To Kagaku Ryoho. 2007 Nov;34(11):1777-81. Japanese. PubMed
PMID: 18030010.

12: Shigehara K, Kitagawa Y, Nakashima T, Shimamura M, Katayanagi K, Kurumaya H.

[Squamous cell carcinoma of the bladder treated with a new combined chemotherapy
regimen, intraarterial nedaplatin and pirarubicin plus intravenous methotrexate
and vincristine--second case report in Japan]. Gan To Kagaku Ryoho. 2007
Aug;34(8):1319-21. Japanese. PubMed PMID: 17687223.

13: Matsumoto H, Hirai T, Hirabayashi Y, Murakami H, Higashida M, Kawabe Y,

Urakami A, Yamashita K, Tsunoda T. [A feasible study of docetaxel/nedaplatin
combined chemotherapy for relapsed or refractory esophageal cancer patients as a
2nd-line chemotherapy]. Gan To Kagaku Ryoho. 2007 May;34(5):725-8. Japanese.
PubMed PMID: 17496445.

14: Maruoka Y, Ando T, Ogiuchi Y, Ogiuchi H. [Nedaplatin (NDP)-combination

therapy (NDP/5-FU,NDP/S-1) for oral cancer]. Gan To Kagaku Ryoho. 2007
May;34(5):713-7. Japanese. PubMed PMID: 17496443.

15: Fuwa N, Kodaira T, Furutani K, Tachibana H, Nakamura T, Daimon T.

Chemoradiation therapy using radiotherapy, systemic chemotherapy with
5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for
locally advanced head and neck cancer - Phase II study. Oral Oncol. 2007
Nov;43(10):1014-20. Epub 2007 Jan 26. PubMed PMID: 17258494.

16: Shigehara K, Kitagawa Y, Nakashima T, Shimamura M. Squamous cell carcinoma of

the bladder: a patient treated successfully with a new combined chemotherapy
regimen, intraarterial nedaplatin and pirarubicin plus intravenous methotrexate
and vincristine. Int J Clin Oncol. 2006 Aug;11(4):329-31. PubMed PMID: 16937309.

17: Niioka T, Uno T, Yasui-Furukori N, Takahata T, Shimizu M, Sugawara K,

Tateishi T. Pharmacokinetics of low-dose nedaplatin and validation of AUC
prediction in patients with non-small-cell lung carcinoma. Cancer Chemother
Pharmacol. 2007 Apr;59(5):575-80. Epub 2006 Aug 16. PubMed PMID: 16912889.

18: Kawase S, Okuda T, Ikeda M, Ishihara S, Itoh Y, Yanagawa S, Ishigaki T.

Intraarterial cisplatin/nedaplatin and intravenous 5-fluorouracil with concurrent
radiation therapy for patients with high-risk uterine cervical cancer. Gynecol
Oncol. 2006 Sep;102(3):493-9. Epub 2006 Feb 14. PubMed PMID: 16478629.

19: Sato Y, Takayama T, Sagawa T, Okamoto T, Miyanishi K, Sato T, Araki H, Iyama

S, Abe S, Murase K, Takimoto R, Nagakura H, Hareyama M, Kato J, Niitsu Y. A phase
I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in
patients with esophageal cancer. Cancer Chemother Pharmacol. 2006
Nov;58(5):570-6. Epub 2006 Feb 4. PubMed PMID: 16463059.

20: Yoshiike F, Koizumi T, Kitaguchi Y, Hatayama O, Yasuo M, Sasabayashi M,

Wakamatsu H, Fujimoto K, Kubo K. Phase I trial of nedaplatin and paclitaxel for
patients with non-small cell lung cancer. J Chemother. 2005 Oct;17(5):550-4.
PubMed PMID: 16323445.

21: Yamshita Y, Shikimori M, Goto M. [Clinical trial of chemotherapy by

superselective intra-arterial infusion of nedaplatin combined with radiotherapy
for advanced oral cancer]. Gan To Kagaku Ryoho. 2005 Sep;32(9):1267-71. Japanese.
PubMed PMID: 16184922.

22: Lipp HP, Hartmann JT. [Platinum compounds: metabolism, toxicity and
supportive strategies]. Praxis (Bern 1994). 2005 Feb 9;94(6):187-98. Review.
German. PubMed PMID: 15754530.

23: Matsui T, Kano M. [Pharmacodynamics of tongue tissue and plasma after

intraarterial infusion of cis-diammine glycolato platinum (CDGP)]. Nihon
Jibiinkoka Gakkai Kaiho. 2004 Nov;107(11):990-7. Japanese. PubMed PMID: 15624504.

24: Ohbayashi Y, Miyake M, Iwasaki A, Ogawa T, Nagahata S, Toyama Y, Ohkawa M.

[Clinical study for determination of the dosage formula for intra-arterial
infusion chemotherapy with nedaplatin]. Gan To Kagaku Ryoho. 2004
May;31(5):713-6. Japanese. PubMed PMID: 15170978.

25: Kurata T, Tamura K, Yamamoto N, Nogami T, Satoh T, Kaneda H, Nakagawa K,

Fukuoka M. Combination phase I study of nedaplatin and gemcitabine for advanced
non-small-cell lung cancer. Br J Cancer. 2004 Jun 1;90(11):2092-6. PubMed PMID:
15150564; PubMed Central PMCID: PMC2409510.

26: Sekine I, Nokihara H, Horiike A, Yamamoto N, Kunitoh H, Ohe Y, Tamura T,

Kodama T, Saijo N. Phase I study of cisplatin analogue nedaplatin (254-S) and
paclitaxel in patients with unresectable squamous cell carcinoma. Br J Cancer.
2004 Mar 22;90(6):1125-8. PubMed PMID: 15026789; PubMed Central PMCID:
PMC2409664.

27: Ohbayashi Y, Miyake M, Iwasaki A, Ogawa T, Nagahata S, Toyama Y, Ohkawa M.

[Clinical study of the area under the blood concentration-time curve of targeting
intra-arterial infusion chemotherapy with nedaplatin for primary oral cancer].
Gan To Kagaku Ryoho. 2004 Jan;31(1):41-4. Japanese. PubMed PMID: 14750319.

28: Machida S, Ohwada M, Fujiwara H, Konno R, Takano M, Kita T, Kikuchi Y,

Komiyama S, Mikami M, Suzuki M. Phase I study of combination chemotherapy using
irinotecan hydrochloride and nedaplatin for advanced or recurrent cervical
cancer. Oncology. 2003;65(2):102-7. PubMed PMID: 12931014.

29: Umeki H, Yamaguchi Y, Tsugata M, Wakana K, Somekawa Y, Shimabukuro K, Ohara

M, Terauchi T, Ichimura M, Otsuka I, Aso T. [Neoadjuvant intraarterial
chemotherapy with nedaplatin, peplomycin and mitomycin C for advanced cervical
cancer]. Gan To Kagaku Ryoho. 2003 Mar;30(3):377-82. Review. Japanese. PubMed
PMID: 12669397.

30: Inaba H, Tsuda T, Miyazaki A, Watanabe Y, Nakaya S, Koitabashi Y, Ogihara K,

Hara T, Kato N, Kobayashi Y, Nakagawa T, Kitajima S, Endo T, Iino S, Hoshikawa Y.
[Clinical study of the combination of small amount of nedaplatin (CDGP)/5-FU with
radiation for the treatment of esophageal cancer]. Nihon Shokakibyo Gakkai
Zasshi. 2002 Oct;99(10):1191-6. Japanese. PubMed PMID: 12415854.

31: Yamashita Y, Goto M, Katsuki T. [Chemotherapy by superselective intraarterial

infusion of nedaplatin combined with radiotherapy for oral cancer]. Gan To Kagaku
Ryoho. 2002 Jun;29(6):905-9. Japanese. PubMed PMID: 12090042.

32: Adachi S, Ogasawara T, Tsubamoto H, Oku H, Hori Y, Tsuji Y, Takemura T,

Koyama K. Intravenous nedaplatin and intraarterial cisplatin with transcatheter
arterial embolization for patients with locally advanced uterine cervical cancer.
Int J Clin Pharmacol Res. 2001;21(3-4):105-10. PubMed PMID: 12067139.

33: Fuwa N. [Current and future state of chemoradiotherapy for head and neck
cancer]. Nihon Igaku Hoshasen Gakkai Zasshi. 2002 Feb;62(2):65-72. Review.
Japanese. PubMed PMID: 11905034.

34: Kamiura S, Kobayashi K, Ohira H, Seino H, Hashimoto N, Sawai K, Samejima Y,

Saji F. [Concurrent chemoradiation therapy with nedaplatin for high-risk cervical
cancer--clinical investigation of adverse events]. Gan To Kagaku Ryoho. 2001
Jul;28(7):979-86. Japanese. PubMed PMID: 11478148.

35: Iwasaki A, Toyama Y, Saitou H, Ohkubo N, Imagawa N, Ogawa T, Ohbayashi Y,

Tanizaki A, Miyake M, Nagahata S, Hino I, Ohkawa M. [Targetting intra-arterial
infusion chemotherapy with nedaplatin for oral cancer]. Gan To Kagaku Ryoho. 2001
Jul;28(7):1027-33. Japanese. PubMed PMID: 11478134.

36: Adachi S, Ogasawara T, Wakimoto E, Tsuji Y, Takemura T, Koyama K, Takayasu Y,

Inoue J, Nakao N. Phase I/II study of intravenous nedaplatin and intraarterial
cisplatin with transcatheter arterial embolization for patients with locally
advanced uterine cervical carcinoma. Cancer. 2001 Jan 1;91(1):74-9. PubMed PMID:
11148562.

37: Kitami A, Suzuki T, Kamio Y, Suzuki S, Hori G, Ueshima Y, Suzuki H. [Thymic

carcinoma successfully treated by a combination of intra-arterial infusion
chemotherapy and surgery]. Nihon Kokyuki Gakkai Zasshi. 2000 Feb;38(2):122-5.
Japanese. PubMed PMID: 10774171.
38: Nishida M, Satoh Y, Nishide K, Tsunoda H, Kubo T. [Phase I study of a
combination chemotherapy of nedaplatin and cisplatin]. Gan To Kagaku Ryoho. 1999
Dec;26(14):2209-15. Japanese. PubMed PMID: 10635306.

39: Ito K, Adachi S, Itani Y, Koyama M, Hori K, Chin R, Shintani M, Beppu K,

Kawai S, Saito K. A dose-finding study of nedaplatin and cyclophosphamide for
patients with gynecological malignancies. Jpn J Clin Oncol. 1999
Jun;29(6):299-302. PubMed PMID: 10418559.

40: Satoh T, Tsushima K, Saitoh S, Hizawa Y, Tamura Y, Fukuda S, Yamada Y, Tohno

H, Takasugi T, Sakata Y, Munakata A. A case of advanced esophageal cancer showing
a long-term complete response with chemotherapy with nedaplatin alone. Jpn J Clin
Oncol. 1999 Feb;29(2):106-8. PubMed PMID: 10089952.

41: Muramatsu S, Ku Y, Kuroda Y. [Pharmacokinetic comparison between cisplatin

and nedaplatin in hepatic arterial chemotherapy using complete hepatic venous
isolation and charcoal hemoperfusion]. Gan To Kagaku Ryoho. 1998
Jul;25(9):1457-60. Japanese. PubMed PMID: 9703853.

42: Adachi S, Yamasaki N, Ogasawara T, Takayasu Y, Takemura T, Koyama K.

Combination chemotherapy using intravenous nedaplatin (254-S) and intraarterial
cisplatin (CDDP) with transcatheter arterial embolization (TAE) for a patient
with uterine cervical cancer: a case report. Jpn J Clin Oncol. 1997
Dec;27(6):442-4. PubMed PMID: 9438011.

43: Kigawa J, Minagawa Y, Itamochi H, Kanamori Y, Ishihara H, Terakawa N.

Platinum concentrations in uterus and serum after internal iliac arterial
infusion of platinum compounds in rabbits. Obstet Gynecol. 1995 Aug;86(2):265-8.
PubMed PMID: 7617358.

44: Ota K, Oguma T, Shimamura K. Pharmacokinetics of platinum in cancer patients

following intravenous infusion of cis-diammine(glycolato)platinum, 254-S.
Anticancer Res. 1994 May-Jun;14(3B):1383-7. PubMed PMID: 8067710.

45: Hirabayashi K, Okada E. Combination chemotherapy with 254-S, ifosfamide, and

peplomycin for advanced or recurrent cervical cancer. Cancer. 1993 May
1;71(9):2769-75. PubMed PMID: 7682148.

46: Koyama H, Ogawa M, Kuraishi Y, Tominaga K, Yoshida M, Taguchi T. [A phase II

clinical study of cis-diammine glycolato platinum, 254-S, for advanced breast
cancer]. Gan To Kagaku Ryoho. 1992 Jul;19(7):1049-53. Japanese. PubMed PMID:
1626940.

47: Noda K, Ikeda M, Yakushiji M, Nishimura H, Terashima Y, Sasaki H, Hata T,

Kuramoto H, Tanaka K, Takahashi T, et al. [A phase II clinical study of
cis-diammine glycolato platinum, 254-S, for cervical cancer of the uterus]. Gan
To Kagaku Ryoho. 1992 Jun;19(6):885-92. Japanese. PubMed PMID: 1605666.

48: Inuyama Y, Miyake H, Horiuchi M, Hayasaki K, Komiyama S, Ota K. [A late phase

II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck
cancers]. Gan To Kagaku Ryoho. 1992 Jun;19(6):871-7. Japanese. PubMed PMID:
1605665.

49: Inuyama Y, Miyake H, Horiuchi M, Hayasaki K, Komiyama S, Ota K. [An early

phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and
neck cancers]. Gan To Kagaku Ryoho. 1992 Jun;19(6):863-9. Japanese. PubMed PMID:
1605664.

50: Ota K, Wakui A, Majima H, Niitani H, Inuyama Y, Ogawa M, Ariyoshi Y, Yoshida

O, Taguchi T, Kimura I, et al. [Phase I study of a new platinum complex 254-S,
cis-diammine (glycolato)-platinum (II)]. Gan To Kagaku Ryoho. 1992
Jun;19(6):855-61. Japanese. PubMed PMID: 1605663.

51: Furuse K, Fukuoka M, Kurita Y, Ariyoshi Y, Niitani H, Yoneda S, Fujii M,

Hasegawa K, Nishiwaki Y, Tamura M, et al. [A phase II clinical study of
cis-diammine glycolato platinum, 254-S, for primary lung cancer]. Gan To Kagaku
Ryoho. 1992 Jun;19(6):879-84. Japanese. PubMed PMID: 1318698.

52: Taguchi T, Wakui A, Nabeya K, Kurihara M, Isono K, Kakegawa T, Ota K. [A

phase II clinical study of cis-diammine glycolato platinum, 254-S, for
gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group]. Gan To
Kagaku Ryoho. 1992 Apr;19(4):483-8. Japanese. PubMed PMID: 1558398.

53: Sasaki Y, Amano T, Morita M, Shinkai T, Eguchi K, Tamura T, Ohe Y, Kojima A,

Saijo N. Phase I study and pharmacological analysis of
cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered by 5-day
continuous intravenous infusion. Cancer Res. 1991 Mar 1;51(5):1472-7. PubMed
PMID: 1997185.

54: Hirabayashi K, Okada E, Oguma T, Shimamura K. [Pharmacokinetics of

cis-diammine (glycolato) platinum (254-S), a new platinum antitumor agent,
following an intravenous and intraperitoneal infusion bioactive platinum
concentration profile]. Gan To Kagaku Ryoho. 1990 Nov;17(11):2221-7. Japanese.
PubMed PMID: 2241186.